Oaktree Acquisition Corp. III Life Sciences (OACC) EPS (Weighted Average and Diluted) (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported EPS (Weighted Average and Diluted) of $0.06 for Q1 2026, down 14.29% on a YoY basis from $0.07 in Q1 2025, and down 25.0% quarter-over-quarter from $0.08 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) EPS (Weighted Average and Diluted) (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported EPS (Weighted Average and Diluted) for 2 years, with the latest figure at $0.06 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 14.29% year-over-year to $0.06; the trailing twelve-month figure through Mar 2026 stood at $0.3 (changed N/A YoY), and the FY2025 full-year result was $0.3, up 150.0% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.06, down from $0.08 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.08 in Q2 2025, with the low at $0.06 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 0.07
2 Berto Acquisition 312.76 Mn 312.76 Mn - 0.06
3 Centurion Acquisition 312.51 Mn 312.51 Mn - 0.07
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 0.04
5 WEN Acquisition 309.15 Mn 309.15 Mn - 0.08
6 Agriculture & Natural Solutions Acquisition 303.01 Mn 303.01 Mn - 0.07
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 0.07
8 Soulpower Acquisition 265.17 Mn 265.17 Mn - 0.05
9 BTC Development 261.90 Mn 261.90 Mn - 0.05
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - 0.06

Historic Data

Download Data
DateValue
Mar 31, 2026 0.06
Dec 31, 2025 0.08
Sep 30, 2025 0.08
Jun 30, 2025 0.08
Mar 31, 2025 0.07